The Trial Master File (TMF) has long been considered the backbone of clinical trial compliance. It is the primary evidence regulators rely on to confirm that a study was conducted in accordance with Good Clinical Practice (GCP), applicable regulations, and the approved protocol.
Continuous inspection readiness in clinical trials enables sponsors and CROs to maintain real‑time oversight, contemporaneous documentation, and consistent operational control throughout active studies. By embedding inspection‑ready behaviors into daily workflows, organizations reduce compliance risk, strengthen data integrity, and respond confidently to evolving regulatory expectations.
Regulators frequently cite trial master file oversight gaps related to governance, review discipline, and sponsor control rather than missing documents or systems.
TMF completeness vs TMF quality is a critical distinction for inspection readiness. Learn why presence alone isn’t enough and how quality ensures accuracy, timeliness, and regulatory compliance.
Electronic trial master file readiness is driven by governance, structure, and oversight—not technology alone. This article explains how sponsors and CROs assess true eTMF readiness operationally.
